Skip to main content
. 2012 Nov 26;83(6):609–613. doi: 10.3109/17453674.2012.747926

Table 1.

Patient characteristics and mortality

In-hospital mortality
30-day mortality
Alive Dead p-value Alive Dead p-value
n 36,326 1,694 NA 34,210 3,810 NA
Women, n (%) 26,959 (74.2) 969 (57.2) < 0.001 25,671 (75.0) 2,257 (59.2) < 0.001
Age, years a 82.5 (7.7) 86.2 (7.2) < 0.001 82.3 (7.6) 86.1 (7.4) < 0.001
Length of stay (days) b 9 (2–23) 6 (2–20) < 0.001 9 (2–23) 5 (2–18) < 0.001
Time to operation, hours b 22.1 (4.5–64.4) 24.5 (4.6–74.8) < 0.001 22.1 (4.5–64.4) 23 (4.5–69.9) 0.003
ASA, n (%) < 0.001 < 0.001
 ASA 1 3,591 (9.9) 47 (2.8) 3,529 (10.3) 109 (2.9)
 ASA 2 19,068 (52.5) 514 (30.3) 18,334 (53.6) 1,248 (32.8)
 ASA 3 12,054 (33.2) 831 (49.1) 11,025 (32.2) 1,860 (48.8)
 ASA 4 1,594 (4.4) 290 (17.1) 1,309 (3.8) 575 (15.1)
 ASA 5 19 (0.1) 12 (0.7) 13 (0.04) 18 (0.5)
Type of fracture, n (%) < 0.001 < 0.001
 Femoral neck fracture 18,783 (51.7) 766 (45.2) 17,847 (52.2) 1,702 (44.7)
 Pertrochanteric fracture 14,975 (41.2) 781 (46.1) 13,976 (40.9) 1,780 (46.7)
 Subtrochanteric fracture 2,568 (7.1) 147 (8.7) 2,387 (7.0) 328 (8.6)

a Values are mean (SD).

b Values are median (range).

ASA score, 1–5: ASA 1, normal healthy patient; ASA 2, mild systemic disease; ASA 3, severe systemic disease; ASA 4, severe systemic disease that is a constant threat to life; ASA 5, a moribund patient who is not expected to survive more than 24 h with or without an operation.

NA: not applicable.